Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incretin and SGLT2i in T2DM Patients with Heart Failure and CRT-d
NCT03282136Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Sep 2017
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) and heart failure (HF) (3 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoints: All Cause Mortality at 12 months, Cardiac Cause Mortality at 12 months and 1 more. Started Sep 2017; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on NCT03282136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282136.